Skip to content

Potential effect of ketamine in treatment for dextromethorphan use disorder exploding in Japanese young population.

Kaori Ishii, Kyoji Okita

Asian Journal of Psychiatry September 1, 2024 DOI: 10.1016/j.ajp.2024.104164 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Topics Anxiety Depression Ketamine Esketamine
Keywords Dextromethorphan Over-the-counter medication Self medication Trauma Mental-health depression Psychological disorders Substance-abuse addiction Drug misuse Self-medication Treatment-alternatives therapy options Clinical interventions Ketamine therapy Japan-healthcare japanese medicine Asian healthcare
Citations 1
Key points Proposes that ketamine may be a useful alternative pharmacological treatment for patients with dextromethorphan use disorders who have severe trauma-related and mood symptoms.

Abstract

In Japan, the landscape of clinical practice for substance use disorder is changing significantly, primarily due to an increase in patients using over-the-counter drugs. A major concern is the rising number of patients misusing dextromethorphan (DXM). These patients with DXM use disorders often have severe trauma-related and mood symptoms, and therefore try to cope with those symptoms by self-medicating with DXM. In this article, we propose that ketamine, which has similar psychopharmacological effects to DXM, may be a useful alternative pharmacological treatment for these patients.

Comparable studies

Other theoretical and historical papers on ketamine for anxiety, most cited first.

Study Year Design Participants
Arketamine for cognitive impairment in psychiatric disorders 2023 Theoretical or philosophical paper
Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches 2022 Theoretical or philosophical paper

Explore topics

By condition and practice